Jeffrey A Tice

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Screening and prevention of breast cancer in primary care
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 1701 Divisadero Street, Suite 554, San Francisco, CA 94143 1732, USA
    Prim Care 36:533-58. 2009
  2. ncbi request reprint Risk factors for mortality in middle-aged women
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, CA 94143, USA
    Arch Intern Med 166:2469-77. 2006
  3. pmc Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143 1732, USA
    Ann Intern Med 148:337-47. 2008
  4. ncbi request reprint Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA 94143 1732, USA
    Breast Cancer Res Treat 94:115-22. 2005
  5. pmc Perceived versus objective breast cancer risk in diverse women
    Julia Fehniger
    1 Department of Medicine, Division of General Internal Medicine, University of California, San Francisco, California
    J Womens Health (Larchmt) 23:420-7. 2014
  6. pmc Benign breast disease, mammographic breast density, and the risk of breast cancer
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA 94143 0320, USA
    J Natl Cancer Inst 105:1043-9. 2013
  7. ncbi request reprint Are breast density and bone mineral density independent risk factors for breast cancer?
    Karla Kerlikowske
    Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    J Natl Cancer Inst 97:368-74. 2005
  8. ncbi request reprint An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia
    Bradly P Jacobs
    Department of Medicine, Osher Center for Integrative Medicine, University of California San Francisco, California, USA
    Medicine (Baltimore) 84:197-207. 2005
  9. ncbi request reprint A randomized, controlled trial to increase discussion of breast cancer in primary care
    Celia P Kaplan
    Authors Affiliations Department of Medicine, Division of General Internal Medicine Helen Diller Family Comprehensive Cancer Center and Medical Effectiveness Research Center for Diverse Populations, University of California San Francisco, San Francisco, California
    Cancer Epidemiol Biomarkers Prev 23:1245-53. 2014
  10. ncbi request reprint Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 1701 Divisadero Street, Suite 554, San Francisco, CA 94143 1732, USA
    Cancer Epidemiol Biomarkers Prev 14:324-8. 2005

Detail Information

Publications27

  1. doi request reprint Screening and prevention of breast cancer in primary care
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 1701 Divisadero Street, Suite 554, San Francisco, CA 94143 1732, USA
    Prim Care 36:533-58. 2009
    ....
  2. ncbi request reprint Risk factors for mortality in middle-aged women
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, CA 94143, USA
    Arch Intern Med 166:2469-77. 2006
    ..Many factors contribute to mortality in older women, but their relative importance and independent contribution have been poorly characterized...
  3. pmc Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California 94143 1732, USA
    Ann Intern Med 148:337-47. 2008
    ..Current models for assessing breast cancer risk are complex and do not include breast density, a strong risk factor for breast cancer that is routinely reported with mammography...
  4. ncbi request reprint Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA 94143 1732, USA
    Breast Cancer Res Treat 94:115-22. 2005
    ..Although the current standard, the Gail model, is well calibrated in populations, it performs poorly for individuals. Mammographic breast density (BD) may improve the predictive accuracy of the Gail model...
  5. pmc Perceived versus objective breast cancer risk in diverse women
    Julia Fehniger
    1 Department of Medicine, Division of General Internal Medicine, University of California, San Francisco, California
    J Womens Health (Larchmt) 23:420-7. 2014
    ..Prior research suggests that women do not accurately estimate their risk for breast cancer. Estimating and informing women of their risk is essential for tailoring appropriate screening and risk reduction strategies...
  6. pmc Benign breast disease, mammographic breast density, and the risk of breast cancer
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA 94143 0320, USA
    J Natl Cancer Inst 105:1043-9. 2013
    ..Benign breast disease and high breast density are prevalent, strong risk factors for breast cancer. Women with both risk factors may be at very high risk...
  7. ncbi request reprint Are breast density and bone mineral density independent risk factors for breast cancer?
    Karla Kerlikowske
    Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    J Natl Cancer Inst 97:368-74. 2005
    ..We determined whether mammographic breast density and BMD of the hip and spine are correlated and independently associated with breast cancer risk...
  8. ncbi request reprint An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia
    Bradly P Jacobs
    Department of Medicine, Osher Center for Integrative Medicine, University of California San Francisco, California, USA
    Medicine (Baltimore) 84:197-207. 2005
    ..Neither kava nor valerian relieved anxiety or insomnia more than placebo. This trial demonstrates the feasibility of conducting randomized, blinded trials entirely via the Internet...
  9. ncbi request reprint A randomized, controlled trial to increase discussion of breast cancer in primary care
    Celia P Kaplan
    Authors Affiliations Department of Medicine, Division of General Internal Medicine Helen Diller Family Comprehensive Cancer Center and Medical Effectiveness Research Center for Diverse Populations, University of California San Francisco, San Francisco, California
    Cancer Epidemiol Biomarkers Prev 23:1245-53. 2014
    ..Assessment and discussion of individual risk for breast cancer within the primary care setting are crucial to discussion of risk reduction and timely referral...
  10. ncbi request reprint Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 1701 Divisadero Street, Suite 554, San Francisco, CA 94143 1732, USA
    Cancer Epidemiol Biomarkers Prev 14:324-8. 2005
    ..Recent guidelines suggest that chemoprevention with tamoxifen may be appropriate for women who have a 5-year risk of breast cancer greater than 1.66% calculated using the Gail model...
  11. ncbi request reprint Aspirin for the primary prevention of cardiovascular disease in women: a cost-utility analysis
    Michael Pignone
    Department of Medicine, Division of General Medicine, University of North Carolina, 5039 Old Clinic Building, Chapel Hill, NC 27599, USA
    Arch Intern Med 167:290-5. 2007
    ..The cost-effectiveness of aspirin for primary prevention of cardiovascular events in women is unclear. We sought to perform a cost-utility analysis to address this issue...
  12. ncbi request reprint Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis
    Mark J Pletcher
    Department of Epidemiology and Biostatistics, University of California, San Francisco, 500 Parnassus Ave, MU 420 West, Box 0560, San Francisco, CA 94143, USA
    Arch Intern Med 164:1285-92. 2004
    ..Measurement of coronary artery calcium has been proposed as a way to improve risk assessment, but it is unknown whether it adds predictive information to standard risk factor assessment...
  13. pmc Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment
    Mitchell D Feldman
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143 0320, USA
    J Gen Intern Med 23:57-63. 2008
    ..Although thousands of drugs obtain approval only after review in randomized controlled trials, relatively few new medical devices are subject to comparable scrutiny...
  14. pmc Introduction: new medical device technologies
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA, USA
    J Gen Intern Med 23:1. 2008
  15. doi request reprint "On the other hand ...": the evidence does not support the use of hand-carried ultrasound by hospitalists
    Mitchell D Feldman
    Department of Medicine, Division of General Internal Medicine, University of California, San Francisco, California 94143 0320, USA
    J Hosp Med 5:168-71. 2010
    ..Novelty, availability, and the results of a few small studies lacking patient-centered outcomes remain insufficient grounds to justify the expanded clinical utilization of these medical imaging devices by nonspecialists...
  16. ncbi request reprint Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco 94143, USA
    JAMA 290:207-14. 2003
    ..Dietary supplements containing isoflavones are widely used as alternatives to hormonal therapies for hot flashes, but there is a paucity of data supporting their efficacy...
  17. pmc Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin
    Kirsten Neudoerffer Kangelaris
    Division of General Internal Medicine, University of California, Box 0131, 533 Parnassus Ave, San Francisco, CA 94143 0131, USA
    J Gen Intern Med 24:656-64. 2009
    ..Genotype-guided initial warfarin dosing may reduce over-anticoagulation and serious bleeding compared to a one-dose-fits-all dosing method...
  18. doi request reprint Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143 1732, USA
    Am J Med 121:885-93. 2008
    ..This study evaluated the balance of patient-oriented clinical outcomes for laparoscopic adjustable gastric banding and Roux-en-Y gastric bypass...
  19. ncbi request reprint The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women
    Jeffrey A Tice
    Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA
    Am J Med 114:199-205. 2003
    ..To determine whether serum C-reactive protein levels, a sensitive indicator of inflammation, are associated with the risk of cardiovascular mortality among older women...
  20. pmc What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk
    Mark J Pletcher
    Department of Epidemiology and Biostatistics, University of California, San Francisco 500 Parnassus Ave, MU 420 West, Box 0560, San Francisco, CA 94143 0560, USA
    BMC Med 2:31. 2004
    ..We sought to combine information from the CAC score with information from conventional cardiac risk factors to produce post-test risk estimates, and to determine whether the score may add clinically useful information...
  21. ncbi request reprint Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force
    Angela Fowler-Brown
    Division of General Internal Medicine, University of North Carolina at Chapel Hill and Cecil G Sheps Center for Health Services Research, Chapel Hill, NC 27599 7110, USA
    Ann Intern Med 140:W9-24. 2004
    ..Coronary heart disease is the leading cause of morbidity and mortality in the United States. Exercise tolerance testing has been proposed as a means of better identifying asymptomatic patients at high risk for coronary heart disease events...
  22. ncbi request reprint Prospective breast cancer risk prediction model for women undergoing screening mammography
    William E Barlow
    Cancer Research and Biostatistics, 1730 Minor Avenue, Suite 1900, Seattle, WA 98101, USA
    J Natl Cancer Inst 98:1204-14. 2006
    ..We used prospective risk information to predict a diagnosis of breast cancer in a cohort of 1 million women undergoing screening mammography...
  23. ncbi request reprint Effect of isoflavones on lipids and bone turnover markers in menopausal women
    Tamara M Knudson Schult
    Center for Chronic Disease Outcomes Research, Minneapolis VA Medical Center, MN 55417, USA
    Maturitas 48:209-18. 2004
    ..The purpose of this analysis was to compare the effects of two dietary supplements derived from red clover to placebo on lipids and bone turnover markers in symptomatic menopausal women...
  24. ncbi request reprint Use of coronary calcification scores to predict coronary heart disease
    Mark J Pletcher
    JAMA 291:1831-2; author reply 1832-3. 2004
  25. ncbi request reprint Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis
    Michael Pignone
    University of North Carolina Division of General Internal Medicine, and RTI University of North Carolina Center for Health Promotion Economics, Chapel Hill, North Carolina 27599 7110, USA
    Ann Intern Med 144:326-36. 2006
    ..Aspirin and statins are both effective for primary prevention of coronary heart disease (CHD), but their combined use has not been well studied...
  26. ncbi request reprint Point-counterpoint: soy intake for breast cancer patients
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    Integr Cancer Ther 1:90-100. 2002
  27. ncbi request reprint Alternatives to estrogen for treatment of hot flashes: are they effective and safe?
    Jeffrey A Tice
    JAMA 295:2076-8. 2006